Actavis Launches Amlodipine Tablets In US - eMaxHealth.com

Actavis Launches Amlodipine Tablets In USeMaxHealth.com, NC - 4 hours agoActavis Group, the international generic pharmaceuticals company, today announced that it has received final approval of amlodipine besylate tablets from …Actavis Launches Carvedilol Tablets in the US PR Newswire (press release)all 8 news articles

Read full story

Comments

Study shows Rasilez(R), the first and only approved direct renin … - PipelineReview.com (press release)

Study shows Rasilez(R), the first and only approved direct renin …PipelineReview.com (press release), Spain - Sep 3, 2007Aliskiren as add-on to amlodipine provides significant additional blood pressure lowering without increased oedema associated with doubling the amlodipine …

Read full story

Comments

First Product in a New Class of Medicine to Treat High Blood … - Earthtimes.org

First Product in a New Class of Medicine to Treat High Blood …Earthtimes.org - 11 hours agoAliskiren as add-on to amlodipine provides significant additional blood pressure lowering without increased oedema associated with doubling the amlodipine …

Read full story

Comments

Daiichi Sankyo and Forest Laboratories sign letter of intent for … - PipelineReview.com (press release)

Daiichi Sankyo and Forest Laboratories sign letter of intent for …PipelineReview.com (press release), Spain - Aug 22, 2007… the calcium channel blocker amlodipine besylate and the angiotensin receptor blocker olmesartan medoxomil PARSIPPANY, NJ, USA and NEW YORK, NY, …

Read full story

Comments

Novartis expands on Rasilez news - DrugResearcher.com

Novartis expands on Rasilez newsDrugResearcher.com, UK - Aug 29, 2007… a new single-tablet formulation of the two most commonly prescribed branded hypertension drugs Diovan and Pfizer's Norvasc (amlodipine besylate), …

Read full story

Comments

SPP100 (RASILEZ) RECEIVES EU APPROVAL - Market Wire (press release)

SPP100 (RASILEZ) RECEIVES EU APPROVALMarket Wire (press release) - Aug 26, 2007Aliskiren as add-on to amlodipine provides significant additional blood pressure lowering without increased oedema associated with doubling the amlodipine …

Read full story

Comments

Novartis expands on Rasilez news - In-PharmaTechnologist.com

Novartis expands on Rasilez newsIn-PharmaTechnologist.com, UK - 9 hours ago… a new single-tablet formulation of the two most commonly prescribed branded hypertension drugs Diovan and Pfizer's Norvasc (amlodipine besylate), …Rasilez(R) receives EU approval, the first major innovation in … PipelineReview.com (press release)all 30 news articles

Read full story

Comments

Rasilez Receives EU Approval, the First Major Innovation in High … - PharmaLive.com (press release)

Rasilez Receives EU Approval, the First Major Innovation in High …PharmaLive.com (press release), PA - Aug 27, 2007Aliskiren as add-on to amlodipine provides significant additional blood pressure lowering without increased oedema associated with doubling the amlodipine …

Read full story

Comments

Pfizer and B-MS see potential in DGAT-1 inhibitors - Pharma Times (subscription)

Pfizer and B-MS see potential in DGAT-1 inhibitorsPharma Times (subscription), UK - 29 minutes agoGeneric competition on a number of blockbusters, including the antihypertensive Norvasc (amlodipine), the antidepressant Zoloft (sertraline) and the …

Read full story

Comments

Rasilez(R) receives EU approval, the first major innovation in … - PipelineReview.com (press release)

Rasilez(R) receives EU approval, the first major innovation in …PipelineReview.com (press release), Spain - 2 hours agoAliskiren as add-on to amlodipine provides significant additional blood pressure lowering without increased oedema associated with doubling the amlodipine …

Read full story

Comments

· « Previous entries